Original Article

You have free access to this content

Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis

  1. Thomas Palm ChE1,
  2. Dominique Figarella-Branger MD, PhD2,
  3. Françoise Chapon MD, PhD3,
  4. Catherine Lacroix MD4,
  5. Françoise Gray MD, PhD5,
  6. Francesco Scaravilli MD, PhD6,
  7. David W. Ellison MD, PhD7,
  8. Isabelle Salmon MD, PhD8,
  9. Miikka Vikkula MD, PhD1,†,
  10. Catherine Godfraind MD, PhD9,†,‡,*

Article first published online: 17 JUN 2009

DOI: 10.1002/cncr.24476

Issue

Cancer

Cancer

Volume 115, Issue 17, pages 3955–3968, 1 September 2009

Additional Information

How to Cite

Palm, T., Figarella-Branger, D., Chapon, F., Lacroix, C., Gray, F., Scaravilli, F., Ellison, D. W., Salmon, I., Vikkula, M. and Godfraind, C. (2009), Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis. Cancer, 115: 3955–3968. doi: 10.1002/cncr.24476

Author Information

  1. 1

    Laboratory of Human Molecular Genetics, Duve Institute, Catholic University of Louvain, Brussels, Belgium

  2. 2

    Department of Pathology and Neuropathology, La Timone's Hospital, AP-HM and EA3281, University of the Mediterranean, Marseille, France

  3. 3

    Laboratory of Pathology, CHU-Caen, Caen, France

  4. 4

    Laboratory of Pathology, Hôpital Kremlin-Bicêtre, Paris, France

  5. 5

    Department of Pathology, APHP Hôpital Lariboisière, Université Paris VII, Paris, France

  6. 6

    Department of Neuropathology, Institute of Neurology, Queen Square, University College London, London, United Kingdom

  7. 7

    Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee

  8. 8

    Laboratory of Pathology, Erasmus University Hospital, Free University of Brussels, Brussels, Belgium

  9. 9

    Neuroscience Center, Laboratory of Neuropathology, Catholic University of Louvain, Brussels, Belgium

  1. †

    The last 2 authors contributed equally to this work.

  2. ‡

    Fax: (011) 32-2-764-74-60

*Laboratory of Pathology, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Avenue Hippocrate, 10, 1200 Brussels, Belgium

Publication History

  1. Issue published online: 20 AUG 2009
  2. Article first published online: 17 JUN 2009
  3. Manuscript Accepted: 5 FEB 2009
  4. Manuscript Revised: 13 JAN 2009
  5. Manuscript Received: 17 SEP 2008

Funded by

  • Fonds Maisin (UCL)
  • Fédération belge contre le cancer
  • Fonds pour la formation á la recherche dans l'industrie et l'agriculture

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (1653K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Khalida Wani, Terri S. Armstrong, Elizabeth Vera-Bolanos, Aditya Raghunathan, David Ellison, Richard Gilbertson, Brian Vaillant, Stewart Goldman, Roger J. Packer, Maryam Fouladi, Ian Pollack, Tom Mikkelsen, Michael Prados, Antonio Omuro, Riccardo Soffietti, Alicia Ledoux, Charmaine Wilson, Lihong Long, Mark R. Gilbert, Ken Aldape, A prognostic gene expression signature in infratentorial ependymoma, Acta Neuropathologica, 2012, 123, 5, 727

    CrossRef

  2. 2
    Isaac Yang, Daniel T. Nagasawa, Won Kim, Marko Spasic, Andy Trang, Daniel C. Lu, Neil A. Martin, Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas, Journal of Clinical Neuroscience, 2012, 19, 6, 779

    CrossRef

  3. 3
    Jacques Grill, Guillaume Bergthold, Céline Ferreira, Pediatric ependymomas, Current Opinion in Oncology, 2011, 23, 6, 638

    CrossRef

  4. 4
    Hazel A. Rogers, John-Paul Kilday, Cerys Mayne, Jennifer Ward, Martyna Adamowicz-Brice, Ed C. Schwalbe, Steven C. Clifford, Beth Coyle, Richard G. Grundy, Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death, Acta Neuropathologica, 2011, 123, 5, 711

    CrossRef

  5. 5
    P. Metellus, J. Guyotat, O. Chinot, A. Durand, M. Barrie, R. Giorgi, A. Jouvet, D. Figarella-Branger, Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients, Neuro-Oncology, 2010, 12, 9, 976

    CrossRef

  6. 6
    Thomas Palm, Jens C. Schwamborn, Brain tumor stem cells, Biological Chemistry, 2010, 391, 6, 607

    CrossRef

  7. 7
    R. Senetta, C. Miracco, S. Lanzafame, L. Chiusa, R. Caltabiano, A. Galia, G. Stella, P. Cassoni, Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes, Neuro-Oncology, 2010, 13, 2, 176

    CrossRef

  8. 8
    H. Xie, M. Wang, M. d. F. Bonaldo, V. Rajaram, W. Stellpflug, C. Smith, K. Arndt, S. Goldman, T. Tomita, M. B. Soares, Epigenomic analysis of Alu repeats in human ependymomas, Proceedings of the National Academy of Sciences, 2010, 107, 15, 6952

    CrossRef

  9. 9
    Valerie N. Barton, Andrew M. Donson, Bette K. Kleinschmidt-DeMasters, Diane K. Birks, Michael H. Handler, Nicholas K. Foreman, Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma, Brain Pathology, 2010, 20, 3
    Direct Link:
  10. 10
    Marc R. Del Bigio, Ependymal cells: biology and pathology, Acta Neuropathologica, 2009, 119, 1, 55

    CrossRef

View Full Article (HTML) Get PDF (1653K)